# CVE-2025-62575: Mirion Medical EC2 Software NMIS BioDose Incorrect Permission Assignment for Critical Resource

> Default SQL user accounts have sysadmin privileges, allowing remote code execution via stored procedures in Mirion Medical dosimetry software.

- **Severity:** High 8.7 (`CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N`)
- **Exploited in the wild:** Not known
- **Login needed:** Any signed-in user
- **Attackable:** Over the internet
- **Victim action needed:** Not needed
- **Fix available:** No
- **Published:** 2 Dec 2025
- **Updated:** 2 Dec 2025
- **Also known as:** GHSA-959v-frv4-7fj8

## What is CVE-2025-62575?

CVE-2025-62575 is a high-severity vulnerability in Mirion Medical EC2 Software NMIS BioDose, published on 2 Dec 2025. Any signed-in user can exploit it over the network, with no action from the victim.

### Official description

NMIS/BioDose V22.02 and previous versions rely on a Microsoft SQL Server database. The SQL user account 'nmdbuser' and other created accounts by default have the sysadmin role. This can lead to remote code execution through the use of certain built-in stored procedures.

Weakness: CWE-732 (Incorrect Permission Assignment for Critical Resource)

## Which versions are affected by CVE-2025-62575?

It affects 1 product.


Products: Mirion Biodose\/Nmis.

## How do I fix CVE-2025-62575?

No fix has been published for CVE-2025-62575 yet. Limit exposure of the affected software until one is available.

## Is CVE-2025-62575 being exploited?

There is no known exploitation of CVE-2025-62575 in the wild and no public exploit code.

## Other vulnerabilities in Mirion Medical EC2 Software NMIS BioDose

- [CVE-2025-61940](https://insights.sbomify.com/CVE-2025-61940/): Mirion Medical EC2 Software NMIS BioDose Use of Client-Side Authentication (high 8.7)
- [CVE-2025-64298](https://insights.sbomify.com/CVE-2025-64298/): Mirion Medical EC2 Software NMIS BioDose Incorrect Permission Assignment for Critical Resource (high 8.6)
- [CVE-2025-64778](https://insights.sbomify.com/CVE-2025-64778/): Mirion Medical EC2 Software NMIS BioDose Use of Hard-coded Credentials (high 8.4)
- [CVE-2025-64642](https://insights.sbomify.com/CVE-2025-64642/): Mirion Medical EC2 Software NMIS BioDose Incorrect Permission Assignment for Critical Resource (high 7.1)

## Fix prompt for AI coding agents

```text
Check this codebase for CVE-2025-62575 and fix it if it is affected.

What it is: CVE-2025-62575 is a high-severity vulnerability in Mirion Medical EC2 Software NMIS BioDose, published on 2 Dec 2025. Any signed-in user can exploit it over the network, with no action from the victim.
Exploitation: There is no known exploitation of CVE-2025-62575 in the wild and no public exploit code.

Affected product: Mirion Medical EC2 Software NMIS BioDose. No package-level version data is available, so check the vendor advisory linked from the reference page.

Task:
1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.
2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.
3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.
4. Run the tests and summarise what changed and why.
5. If nothing in the project is affected, say so and change nothing.

Reference: https://insights.sbomify.com/CVE-2025-62575/ (Markdown: https://insights.sbomify.com/CVE-2025-62575/index.md)
```

## Sources

- CVE record: https://www.cve.org/CVERecord?id=CVE-2025-62575
- NVD: https://nvd.nist.gov/vuln/detail/CVE-2025-62575
- OSV: https://osv.dev/vulnerability/CVE-2025-62575

---
From sbomify Insights: https://insights.sbomify.com/CVE-2025-62575/
Summaries are generated and may contain mistakes; the official description above is the record.